Literature DB >> 17958940

Patient satisfaction with nurse-led telephone follow-up in women with lower urinary tract symptoms.

Stephen Jeffery1, Stergios K Doumouchtsis, Michelle Fynes.   

Abstract

We assessed the clinical effectiveness and patient satisfaction with nurse-led telephone follow-up of women with lower urinary tract symptoms. Participants were offered telephone follow-up with a nurse instead of a conventional outpatient appointment. Suitability was decided by the doctor who saw the women at her last visit. The consultation was conducted using the same principles as a routine clinic visit. Patient satisfaction was evaluated by postal questionnaire and they were also sent a standard urinary continence questionnaire, the Kings Health Questionnaire (KHQ), to evaluate their current symptoms. In total, 116 women were included. The mean number of telephone consultations was 2 (range 1-12). The mean overall satisfaction score was 77 (maximum 100, where a higher score indicates greater satisfaction). Only 16 patients (17%) did not prefer telephone follow-up to a clinic visit. Women who had been discharged via the telephone follow-up clinic expressed similar mean satisfaction scores to those whose next visit was a clinic visit (80 and 82, respectively). The KHQ also indicated that the patients had been appropriately discharged or given a further follow-up appointment. Nurse-led telephone follow-up is associated with high satisfaction and has the advantages of consistent follow-up by the same clinician, convenience to the patient and cost-savings.

Entities:  

Mesh:

Year:  2007        PMID: 17958940     DOI: 10.1258/135763307782215424

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  1 in total

1.  Patient Satisfaction With Nurse-Led Telephone Follow-up in an Ambulatory Setting.

Authors:  Megan O Schimpf; Dee E Fenner; Tovia M Smith; Julie Tucker; Mitchell B Berger
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Nov/Dec       Impact factor: 2.091

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.